Last reviewed · How we verify

NCT06615297

Mimic Muscle Volume, Central Facial Palsy Severity and Dysphagia

Not yet recruiting Last updated 26 September 2024
What this trial tests

trial testing ultrasonographic evaluation in Facial Paralysis, Central in 70 participants. Not yet recruiting.

Timeline
1 October 2024
Primary endpoint
1 March 2025
1 April 2025

Quick facts

Lead sponsorIstanbul Physical Medicine Rehabilitation Training and Research Hospital
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment70
Start date1 October 2024
Primary completion1 March 2025
Estimated completion1 April 2025

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Who can join

18 and older, any sex, with Facial Paralysis, Central or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

70 stroke patients with central facial paralysis will be included and their demographic data will be questioned and facial nerve thickness, depressor labi inferior, depressor anguli oris, buccinator and risorius muscles will be evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ultrasonographic evaluation

Trials testing the same drug.

Other Istanbul Physical Medicine Rehabilitation Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06615297.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing